Athletes might get tested anytime and anywhere without previous notice, no matter if they are included in an FIAU Registered Testing Pool (RTP) or not. Generally we distinguish In-competition testing and Out-of-competition testing. Click on WADA’s Doping Control video to get an explanation of the entire procedure :
This video is also available in Arabic, French, German, Greek, Portuguese, Russian and Spanish and can be accessed on WADA’s movies channel.
Be aware: Refusing, or failing without compelling justification, to submit to Sample collection after notification as authorized in applicable anti-doping rules or otherwise evading Sample collection is considered as an anti-doping rule violation.
RESPONSIBILITY FOR FIAU TESTING
The FIAU is responsible for overseeing all testing conducted by FIAU. Tests will only be conducted by qualified individuals who have been authorised by the FIAU.
SELECTION OF ATHLETES TO BE TESTED
At International events, the FIAU Anti-Doping Manager shall determine the number of tests to be performed. He or she shall maximise the diversity of athletes tested, and not necessarily target those linked to final placements.
ATHLETES’ RESPONSIBILITIES INCLUDE (BUT ARE NOT LIMITED TO):
complying with the FIAU Anti-Doping Rules (in line with the World Anti-Doping Code);
being available for sample collection (urine or blood), whether in-competition or out-of-competition;
ensuring that no prohibited substance enters his body and that no prohibited method is used;
making sure that any treatment is not prohibited according to the Prohibited List in force;
applying to the FIAU (or national anti-doping organisation if the athlete is a national level athlete ) if no alternative permitted treatment is possible and a Therapeutic Use Exemption (TUE) is required (see the FIAU TUE application process);
reporting immediately for sample collection after being notified of a doping control;
ensuring the accuracy of the information entered on the doping control form during sample collection (including stating any medications and supplements taken within the seven days prior to sample collection, and where the sample collected is a blood sample, blood transfusions within the previous three months);
cooperating with anti-doping organisations investigating anti-doping rules violations (ADRVs); and
not working with coaches, trainers, physicians or other athlete support personnel who are ineligible on account of an ADRV or who have been criminally convicted or professionally disciplined in relation to doping (see WADA’s Prohibited Association List).
Note: during doping control, the athlete must remain within direct observation of the Doping Control Officer (DCO) or chaperone at all times from when the initial contact is made until the completion of the sample collection procedure. The athlete must also produce identification upon request.
ATHLETES’ RIGHTS INCLUDE (BUT ARE NOT LIMITED TO):
during the doping control:
bringing a representative and, if available, an interpreter;
asking for additional information about the sample collection process;
requesting a delay in reporting to the doping control station for valid reasons (International Standard for Testing and Investigations Art. 5.4.4) ; and
requesting modifications for athletes with impairments (if applicable).
requesting and attending the B sample analysis (in the case of an Adverse Analytical Finding); and
in the case of an Anti-Doping Rule Violation (ADRV) being asserted, the athlete has the right to a fair hearing and the right to appeal the hearing decision.